Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Mar 26, 2012 · 10-K · 86 days after period end · 0001193125-12-132146
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Net Income | -$4.26M | — |
| EPS Diluted | -$0.02 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 26, 2012 · 86 d after period end
